Japanese researchers succeeded in controlling the progression of ALS, in mice by transplanting cells made from iPS cells
- Listed: 06/26/2014 6:43 pm
- Expires: This ad has expired
iPS derived cells help improve ALS in mice
Date: Jun 26, 2014
Source: NHK World
A group of Japanese researchers say they have succeeded in controlling the progression of ALS, also known as Lou Gehrig’s disease, in mice by transplanting cells made from iPS cells, or pluripotent stem cells.
ALS(Amyotrophic lateral sclerosis) is a fatal neuron disease that causes a progressive degeneration of the muscles. Doctors estimate nearly 9,000 people in Japan suffer from it.
The group first used human iPS cell to form “glia cells” that aid the work of motor nerves. They then transplanted the glia cells to the spines of mice that had symptoms of ALS.
They say the average lifetime of the mice without the transplant was 150 days. But the mice that underwent the procedure lived 162 days, nearly 8 percent longer.
The researchers also found the protein that activates motor nerves increased in the mice spines that received the transplant.
Professor Inoue said that after further study, their method could be applied to the treatment of humans.
Focal Transplantation of Human iPSC-Derived Glial-Rich Neural Progenitors Improves Lifespan of ALS Mice
Date: Jun 26, 2014
Source: Stem Cell Reports
- Transplantation of human iPSC-derived cells to spinal cord of ALS model mice
- Transplanted glial-rich NPCs attenuated non-cell autonomous neurodegeneration
- Feasibility study for ALS transplantation is presented
Transplantation of glial-rich neural progenitors has been demonstrated to attenuate motor neuron degeneration and disease progression in rodent models of mutant superoxide dismutase 1 (SOD1)-mediated amyotrophic lateral sclerosis (ALS). However, translation of these results into a clinical setting requires a renewable human cell source. Here, we derived glial-rich neural progenitors from human iPSCs and transplanted them into the lumbar spinal cord of ALS mouse models. The transplanted cells differentiated into astrocytes, and the treated mouse group showed prolonged lifespan. Our data suggest a potential therapeutic mechanism via activation of AKT signal. The results demonstrated the efficacy of cell therapy for ALS by the use of human iPSCs as cell source.
For more details, click here.
Information about the ad poster
- Listed by: JAPAN PRODUCTS
- Member Since: 11/14/2012
Other items listed by JAPAN PRODUCTS
- Japanese Automaker Subaru Sees Record April-June Profit at $778.6 Million
- UACJ, Constellium partnership to supply aluminum sheets to automotive industry
- Mitsubishi Heavy Industries Begins Construction of Next Generation Cruise Ships with Leading-edge Technologies
- Japanese high performance film product used in the national stadium at the Singapore Sports Hub
- Japanese electronics maker NEC to expand largest renewable energy storage system in Europe
Top Ads Today
- Fujiwara Industry Co., Ltd. - Wastewater Treatment and Tsunami Emergency Equipment (20 views)
- Gifu Seiki Kogyo Co., Ltd. - We specialize in precision deep drawing (13 views)
- Nippon Poly-Glu Co., Ltd. - Provides Water Treatment Assistance (12 views)
- SHINKO IND. LTD. - Our Cargo Oil Pumps Occupies 85% of The Global Market (10 views)
- SAGA HIMAT - Heavy Ion Cancer Treatment Center (9 views)
- Nippura Co., Ltd. - Aquarium Manufacturer (9 views)
- Aiya Co., Ltd. - We've been producing the organic matcha green tea since 1885 (8 views)
- Kuken Kogyo Co., Ltd. - Leading manufacturer of cooling tower systems in Japan (8 views)
- Taiseiplas Co., Ltd - Manufacturing of original equipment for variety industrial fields (7 views)
- Nippon Magnetic Dressing Co., Ltd. - Iron and steel slag recycling business and sales sorting machine (7 views)